Invention Grant
- Patent Title: Intravenous injection for enhancing immune function
-
Application No.: US16331590Application Date: 2016-09-08
-
Publication No.: US11213555B2Publication Date: 2022-01-04
- Inventor: Yong Zhang , Youfei Shi
- Applicant: WEIFANG HUAYING BIOTECHNOLOGY CO., LTD. , SHANDONG AGRICULTURAL UNIVERSITY
- Applicant Address: CN Weifang; CN Tai'an
- Assignee: WEIFANG HUAYING BIOTECHNOLOGY CO., LTD.,SHANDONG AGRICULTURAL UNIVERSITY
- Current Assignee: WEIFANG HUAYING BIOTECHNOLOGY CO., LTD.,SHANDONG AGRICULTURAL UNIVERSITY
- Current Assignee Address: CN Weifang; CN Tai'an
- Agency: Bayramoglu Law Offices LLC
- International Application: PCT/CN2016/098444 WO 20160908
- International Announcement: WO2018/045534 WO 20180315
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K35/747 ; A61K35/745 ; A61P37/04
Abstract:
An intravenous injection for enhancing immune function is provided, belonging to the field of biomedicine. The main ingredient of the drug is inactivated lactic acid bacteria, which is prepared by inactivating living lactic acid bacteria.
Public/Granted literature
- US20210023146A1 INTRAVENOUS INJECTION FOR ENHANCING IMMUNE FUNCTION Public/Granted day:2021-01-28
Information query
